⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

AXGN

Axogen, Inc.

Healthcare · Medical Devices

38.06USD

+1.3800 (+3.76%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on AXGN.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 38.06
P/E—
Dvd Ind Yld0.0%
P/B8.71
P/S8.9
Curr EV/T12M EBITDA-327.6
Mkt Cap (USD)2.2B
Curr EV (USD)2.0B
2)

Per Share Data

EPS T12M-0.69
DPS—
Bk Val Per Sh4.78
Rev/Sh4.71
Cash/Sh2.07
Curr Shares Out58.7M
FCF/Sh0.16
3)

Cash Flow Analysis

P/CF148.4
Curr P/FCF259.7
CF/NI-0.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales6.0%
Eff Interest Rate17.4%
4)

Growth Potential

Dil EPS 1Y Gr-47.8%
Cap 1Y Gr17.1%
BPS 1Y Gr19.2%
R&D To Sales14.4%
Retention Rate100.0%
Rev 1Y Gr20.2%
FCF 1Y Gr-304.5%
Assets 1Y Gr8.8%
5)

Profitability

EBITDA-0.0B
EBIT-0.0B
Operating Margin-5.1%
Pretax Margin-6.0%
Net Margin-13.4%
ROA-13.1%
ROE-18.2%
ROC-5.0%
Asset Turnover0.98
6)

Structure

Current Ratio6.60
Quick Ratio4.79
Debt/Assets0.8%
Debt/Com Eq1.0%
Net Debt/EBITDA14.47
Tot Debt/Capital1.0%
Gross Margin74.6%
EBIT/Int Exp-3.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.